FLUTICASONE PROPIONATE | N209022 | PARATEK PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from OptiNose US Inc FDA-2021-P-0530 · 87 docket documents OptiNose US, Inc. filed this citizen petition on May 31, 2021, requesting that the FDA require applicants seeking approval of abbreviated new drug applications and section 505(b)(2) applications referencing XHANCE (fluticasone propionate) nasal spray to demonstrate bioequivalence and therapeutic equ | 505(q) | 2021-06-03 | Open | OptiNose US Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$40.87
per ml
Lowest NADAC/Unit
$40.87
per ml
Brand NDCs
1
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 71143037501XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY | $40.87 | ML | Brand | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.